Joel Greenblatt acquired 17.7 Thousand Corcept Therapeutics shares worth $445 Thousand. That's 0.01% of their equity portfolio (1022nd largest holding). The first Corcept Therapeutics trade was made in Q3 2015. Since then Joel Greenblatt bought shares fifteen more times and sold shares on eighteen occasions. The stake costed the investor $247 Thousand, netting the investor a gain of 80% so far.